bioRxiv preprint doi: https://doi.org/10.1101/2021.04.25.441316; this version posted April 26, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Analysis of viral RNA-host protein interactomes 2 enables rapid antiviral drug discovery 3 Shaojun Zhang1,5, Wenze Huang1,5, Lili Ren2,3,5, Xiaohui Ju4,5, Mingli Gong4,5, 4 Jian Rao2,3, 5, Lei Sun1, Pan Li1, Qiang Ding4,*, Jianwei Wang2,3,*, Qiangfeng Cliff 5 Zhang1,* 6 7 1 MOE Key Laboratory of Bioinformatics, Beijing Advanced Innovation Center for 8 Structural Biology & Frontier Research Center for Biological Structure, Center for 9 Synthetic and Systems Biology, Tsinghua-Peking Joint Center for Life Sciences, 10 School of Life Sciences, Tsinghua University, Beijing, 100084, China 11 2 NHC Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux 12 Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & 13 Peking Union Medical College, Beijing, 100730, China 14 3 Key Laboratory of Respiratory Disease Pathogenomics, Chinese Academy of Medical 15 Sciences and Peking Union Medical College, Beijing, 100730, China 16 4 Center for Infectious Disease Research, School of Medicine, Tsinghua University, 17 Beijing, 100084, China 18 5 Co-first author 19 * Correspondence:
[email protected] (Q.D.),
[email protected] (J.W.), 20
[email protected] (Q.C.Z.) 21 Short title: Viral RNA and host protein interactome 22 Keywords: RNA-protein interaction, SARS-CoV-2, EBOV, ZIKV, drug discovery 23 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.04.25.441316; this version posted April 26, 2021.